Aidot Inc.

2021
COMPANY INTRODUCTION

• Establishment in June 2014.

• AI Solution for Medical & Healthcare

• Solve the medical imbalance by AI technology

• User-friendly UI & Operation

-2
TEAM - ADVISORS
Advisor
Mr.Jeon
• An associate professor of Neurosurgery at Hal-
lym University.
• Research professor at NFRT Stroke Institute at
Hallym University.
• Strategic partner in the field of artificial in-
telligence business for cerebral-hemorrhage
and cerebral infarction in Aidot
• Shareholders of Aidot.
Advisor
Mr.Seok
• The director of Gastroenterology at Hallym
University Chuncheon Sacred Heart Hospi-
tal.
• Medical doctor at Yonsei University.
• Joint research director of Gastrointestinal
Endoscopy Project.
Strategic partner in the field of artificial in-
telligence business for Microbiome project in
Aidot.
Advisor
Mr.Kim
• An assistant professor at Ilsan Cha Hospi-
tal's Women's Oncology Center.
• Went on for a doctorate at Korea Univer-
sity.
• Gynecologic cancer and oncology expert.
The consultant of domestic and international
advice for cervical cancer in Aidot
Advisor
Mr.Kim
• Professor of Obstetrics and Gynecology at
Seoul National University Bundang Hospital.
• Director of Convergence Research at Seoul
National University Bundang Hospital.
• Seoul National University's medical doctor.
• The director of Cervical DB Consignment Re-
search for Cerviray AI.
Advisor
Mr.Bang
• Professor of Gastroenterology at Hallym
University Chuncheon Sacred Heart Hospi-
tal.
• Medical doctor at Dankook University.
• Joint research director of Gastrointestinal
Endoscopy
Strategic Project.
partner in the field of artificial in-
telligence business for gastroenterology in
Aidot.
Advisor
Mr.Oh
• An assistant professor of emergency
medicine at Hanyang University Hospital.
• Medical doctor at Hanyang University.
• Joint research director for ureterolith
project.
Health Insurance Review and Assessment
Service's project partner for ureterolith in
Aidot
Advisor
Mr.Song
• The director of Obstetrics and Gynecology
at Korea University Anam Hospital.
• Medical doctor at Korea University.
• Gynecologic Oncology expert.
• Authoring the training manual for Cerviray
AI reading.
• Strategic partner in the field of artificial
intelligence business for cervical cancer in
Aidot.
• Shareholders of Aidot.
Advisor
Mr.Lee
• The hospital director of Hallym University
Chuncheon Sacred Heart Hospital.
• Department of anesthesiology.
The joint research stragic partner in the field of
cerebral aneurysm at Asan Hospital and Hallym
University in Aidot.
Advisor
Mr.Lee
• An associate professor of Emergency
Medicine at Seoul National University
• Joint research director for ureterolith
project. Insurance Review and Assessment
Health
Service's project partner for ureterolith in
Aidot
-3
Company Profile – IP (Intellectual Properties)
Patents/trademark rights related AI cervical cancer system and stroke system

No. IP Title IP Area / Account of applications

System for generating cervical learning data and method of classifying KR (2018.08), China (2019.02), KR(2019.10) ,
1 4
cervical learning data (Registered) HK(2020.08)
Method and apparatus for determining whether cervical cancer has oc-
2
curred in subject
KR (2017.11), China (2018.07), PCT (2017.11) 3

3 Deep learning system KR (2019.02), China (2019.05), PCT(2019.08) 3

4 Cervical cancer automatic diagnosis system KR (2019.06), KR (2019.09), PCT(2019.12) 3
Patents Colposcope (Registered) KR (2019.10) 1
(28)
5 Device for obtaining cervical image (Registered) KR (2019.10) 1
6 Cerebral aneurysm rupture prediction system KR (2020.01), PCT (2020.05) 2
Carotid ultrasound diagnosis system KR (2020.03), PCT (2020.09) 2
Carotid ultrasound diagnosis device KR (2020.03), PCT (2020.09) 2
Ultrasound diagnosis system (Registered) KR (2020.09) 1
Trademark
7 12 Brand names (Registered) KR (2019.06) 12
rights (12)
Total 40
Two medical journals have been registered.
Title : “Machine Learning Application for Rupture Risk Assessment in Small-Sized Intracranial Aneurysm”
- Published: AIDOT + Hallym university hospital joint thesis of Switzerland International Journals ‘MDPI’ (2019.5)

-4
Company Profile – Awards

• 2021’s U.S. Trade Council - Won the 1st place in Go Global Medical Technology
• 2021’s Selected among 1,000 national team of innovative company
• 2021’s Japan Osaka Open Innovation Finalist (Korean representative)
• 2021’s Ministry of SMEs and Startups - Selected as promising SMEs for export
• 2020’s The Minister of Science and ICT - Cultural Minister Grand Awards
• 2020’s Ministry of SMEs and Startups - Cultural Minister Awards
• 2020’s The 7th Korea SW Quality Awards- Excellence Awards
• 2020’s Smart Korea Technology Guarantee Fund - Chairman's Awards
• 2020’s China 'Science and Technology Innovation Forum in Northeast Asia' - Won the 1st place (Korean representative)

• 2020’s CIO Advisor - Top Hottest Artificial Intelligence

• 2019’s Japan NTT DATA Open Innovation Finalist (Korean representative)
• 2017’s Ministry of Science and ICT - Cultural Minister Awards
• 2015’s Certified by the Minister of Science, ICT, and Future Planning K-Global 300

-5
Company Profile– Certification

- Medical device manufacturing

license
- Medical device import business
license
- Colposcope: class 1 of KFDA

- AI Software: class 3 of KFDA

(Export use)

- Korean MFDS: class 3 of KGMP

- ISO13485

- Two Patent registration

- AI’s accuracy test report

-6
The status of solution development
Cervical cancer screening – Cerviray AI
Global commercialization stage
 Two patent registrations including
‘Cerviray Camera’.
3rd class of KFDA(Export use), CE,
ISO13485,ISO 9001, 3rd class of KGMP
3rd class of AI software
Approval of the clinical trial plan
(2021.07.08)
 Clinical initiation (2021.10.19)
Prediction of rupture of cerebral aneurysm – NAO dot AI
Thesis writing stage
Multi-center & multi-clinical (CRIS)
completed
SCI-level thesis publication in 2019
Follow-up paper publication in De-
cember 2020
Follow-up R&D centered on re-
searchers at Asan Medical Center
Stroke screening through carotid ultrasound – SONO dot AI
Clinical trial stage
Processing joint clinical trials at four
university hospitals (CRIS)
 Patent registration for
‘Ultrasound diagnosis system’
 certified by the MFDS in Korea
Preparing for global commercialization
CE, KFDA certification (July 2021 started)
Real-time gastrointestinal endoscopy examination – GIGA dot AI
Development stage
Gastroscopy development completed,
Developing an integrated model for
colonoscopy and small intestine cap-
sule endoscopy
"The world's first real-time endo-
scopic artificial intelligence solution
that can be applied clinically"
-7
 Microbiome-based artificial intelligence screening solution for alcoholic liver diseases

Future Biotechnology

Predicting the presence and risk of alcoholic liver disease in advance

through a simple fecal examination at regular checkups.
Microbiome Analysis Artificial Intelligence Solution
On 1st of July , Confirmation of the Special Zone for Regula-
tory Freedom presided over by the Prime Minister
-8
Cerviray AI – Cervical Cancer Remote Reading AI System
Cerviray AI Solution is…

Korea University Anam Hos-

pital Sensitivity : 93%
Digital Colposcope +
+ Seoul National University Specificity : 89%
AI screening system Bundang Hospital
Learned 30,000 IRB ap- Criteria for the official TTA
proved data test results

Features

93
%
1
Days

Accuracy Low cost Takes 1 days

Any medical Database

practitioner of 30,000
can screen patients
- 10
Cerviray AI Certification
AI Software

Class 3 of KFDA(Export use) & KGMP

CE MDD / ISO13485
Approval of class 3 of KFDA's clinical
trial plan in Korea
Colposcope HW

Class 1 of KFDA /
ISO 9001 / ISO 13485

The Health Insurance

Review and Assess-
ment Service's Fee
system

- 11
Cerviray AI as a business model
Sales of Hardware + Reading fee per using AI software

$On-spot readout fee

Compliance with the local Medical Law
& Personal Information Protection Act

$Hardware purchase $Remote readout fee

Photograph cervix and Remote transfer Tele-medicine for reading of cervix photo

Cerviray WAS

Security system

AI DB
Server Server
Cerviray AI in Global Markets

40 partnerships in 16 countries

Russia
Distributorship w/ top med-
ical supply company

Japan
MOU for clinical trial
China
Korea
India JV company
Strategic partnership w/ KCL medical foundation
MOU w/ Diagnosis
company Philippines
EDCF - Government support project
Vietnam
Distributorship w/
3 companies incl. Indonesia
SNET Vina MOU w/ local conglometory company
Paraguay
Distributorship w/ a
pharma company

- 13
Cerviray AI in Phillipine market

https://www.youtube.com/watch?v=OqLipkKDf8g https://www.youtube.com/watch?v=ufIrZgVgp48 https://www.youtube.com/watch?v=VHuKT0lJ458

Introduction and official video of

Cerviray AI during the month of 2021 ICT Business Partnership with CerviQ 2021 WHO Glow Teal Campaign
cervical cancer eradication event
in May.

Philippine gynecologic oncology marketing and EDCF project

are now underway simultaneously.
- 14
Cerviray AI in Korean market

Distribution to 300 obstetrics and gynecology networks of the KCL foundation in Korea
(will applied a step-by-step sales strategy)

Models in stages
Before certification by
Step 1 the MFDS of AI SW

Colposcope HW's supply to hospitals of

KCL Foundation
started their business from July 2021

AI software certification completed

Step 2 (Q1 of 22)

Supply both colposcope HW

and AI Diagnosis Assistance to the hospitals
<Cerviray - Completed interworking work be-
(about 800 hospitals in Korea until early 2022)
tween KCL Foundation systems> - 15
 Comparison table

Appearance

Product name Cerviray Mobile ODT_EVA Kejian-AD MedGyn Leisegang Optik 2 Femicam

Country Korea Israel China U.S. Germany Indonesia

Wire-less Portable/ Opti- Portable/ Optical

Type Portable/ Digital Wheeled/ Digital Wheeled/ Optical/ Digital Portable/ Digital
cal (Magnifying Glass)

Focus Auto + Manual Manual Manual Manual Manual Manual

Zoom 3X ~ 5X Optical 4X Optical 12x Digital 36x Digital 3.75x, 7.5x, 15x Digital Zoom

Energy source Battery driven Battery driven Battery driven Battery driven Cable power Cable power

Light source LED (anti-glare function) LED LED LED LED LED

Green filter Yes Yes Yes Yes Yes No

A.I. Yes No No No No No

Remote diagnosis Yes No No No No No

Display Yes (Embedded) Yes (Mobile Phone) No No No No

 Thank you

Contact us
http://www.aidot.ai
marketing@aidot.com